Version2 Healthcare India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 30-12-2024
- Paid Up Capital ₹ 0.50 M
as on 30-12-2024
- Company Age 10 Year, 15 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 105.32%
(FY 2019)
- Profit 9.95%
(FY 2019)
- Ebitda 10.58%
(FY 2019)
- Net Worth -46.57%
(FY 2019)
- Total Assets -16.25%
(FY 2019)
About Version2 Healthcare India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Version2 Healthcare India Private Limited India is Ramanathan Girish as CEO. Ramanathan Girish and Vedanth Girish serve as directors at the Company.
- CIN/LLPIN
U85110KA2015FTC078198
- Company No.
078198
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
09 Jan 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Version2 Healthcare India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramanathan Girish  | CEO | 09-Jan-2015 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramanathan Girish | Director and Ceo | 09-Jan-2015 | Current |
| Vedanth Girish | Director | 16-Dec-2016 | Current |
Financial Performance of Version2 Healthcare India.
Version2 Healthcare India Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 105.32% increase. The company also saw a slight improvement in profitability, with a 9.95% increase in profit. The company's net worth observed a substantial decline by a decrease of 46.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Version2 Healthcare India?
In 2019, Version2 Healthcare India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Trade Service Private LimitedActive 77 years 11 months
Ramanathan Girish and Vedanth Girish are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Version2 Healthcare India?
Unlock and access historical data on people associated with Version2 Healthcare India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Version2 Healthcare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Version2 Healthcare India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
